A typical course of prednisone for a rheumatoid arthritis flare lasts less than three months, with many flares managed in just a few weeks. The exact duration depends on how severe your flare is, whether your doctor is adjusting your long-term medications at the same time, and how quickly your symptoms respond.
The Standard Timeline
International guidelines from both the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) recommend keeping prednisone courses under three months when treating an RA flare. Most rheumatologists start at 10 to 20 mg per day and aim to get you down to 10 mg or less as quickly as your symptoms allow. Doses under 10 mg per day are considered “low dose” by international standards.
For a straightforward flare where your underlying RA medication is otherwise working well, your doctor may prescribe a shorter burst of one to two weeks at a moderate dose, then taper you off over the following week or two. If flares happen only occasionally, this approach can bring relief without requiring changes to your long-term treatment plan. More frequent flares usually signal that your disease-modifying medication needs adjustment rather than repeated rounds of prednisone.
Prednisone as a Bridge to New Medications
Prednisone often plays a different role when your rheumatologist is starting or switching your disease-modifying antirheumatic drug (DMARD). These medications, including methotrexate and biologic therapies, can take weeks or even months to reach full effectiveness. Prednisone fills that gap, controlling inflammation while the new drug builds up in your system.
In this bridging scenario, you might take prednisone for the full three-month window. EULAR guidelines specifically recommend that bridging courses begin at the same time as the new DMARD, with the goal of tapering off prednisone by three months. Some protocols allow bridging for longer if needed, but the intent is always to get you off prednisone once the DMARD takes over.
How Tapering Works
You should not stop prednisone abruptly, even after a short course. Your body’s natural production of cortisol, a hormone that regulates inflammation and stress, slows down while you’re taking prednisone. Stopping suddenly can leave you without enough cortisol, causing fatigue, joint pain, and nausea that can mimic or worsen a flare.
Tapering typically means reducing your dose by small increments every few days to a week. For example, if you started at 15 mg, your doctor might drop you to 10 mg after a week, then 7.5, then 5, then 2.5 before stopping. The lower the dose gets, the more gradual the steps tend to be, because the last few milligrams are where your adrenal glands need the most time to recover. Your rheumatologist will adjust the pace based on whether your symptoms stay controlled at each lower dose.
Side Effects During a Short Course
Even brief courses of prednisone can cause noticeable side effects. Headache is the most commonly reported issue in short-term use. Many people also experience increased appetite, mild fluid retention, and mood changes like irritability or feeling “wired.” Sleep disruption is a frequent complaint, though clinical sleep assessments in short-term studies haven’t always captured a clear pattern.
Blood sugar effects at typical RA flare doses (under 20 mg) tend to be small and often not clinically significant in people without diabetes. At doses of 20 mg and above, glucose levels can rise more noticeably, which matters if you have diabetes or prediabetes. Your doctor may want to monitor your blood sugar more closely during the course.
Why Longer Courses Raise Concerns
The three-month guideline exists largely because of what happens to your bones. Prednisone accelerates bone loss, and current recommendations call for fracture risk assessment in anyone expected to take 2.5 mg or more per day for longer than three months. That assessment may include a bone density scan (DXA) and a calculation of your overall fracture risk. If you fall into a moderate or high risk category, your doctor may recommend a bone-protecting medication alongside the prednisone.
The exact cumulative dose that triggers bone loss hasn’t been pinpointed, but available data suggests that exceeding about 1 gram of total prednisone in a year (roughly 3 mg per day for a full year) increases fracture risk enough to warrant closer monitoring. Beyond bone health, prolonged use raises the likelihood of weight gain, elevated blood pressure, thinning skin, cataracts, and difficulty controlling blood sugar.
What Determines Your Specific Timeline
Several factors shape how long your course will last. A mild flare in someone whose DMARD is otherwise effective may resolve with just one to two weeks of low-dose prednisone. A severe flare that coincides with a medication change could mean the full three-month bridge. People who have been on prednisone repeatedly or for extended periods in the past may need a slower taper to avoid rebound symptoms.
Your rheumatologist will typically reassess your symptoms within a few weeks of starting prednisone. If your pain and swelling have improved significantly, that’s the signal to begin tapering. If symptoms return as the dose drops, it may indicate that your underlying DMARD regimen isn’t providing enough control, and the conversation shifts to adjusting your long-term treatment rather than extending prednisone. The goal is always to use the lowest effective dose for the shortest time that gets you through the flare.